What is the natural history of ARG1-D disease?
b. What impact does ARG1-D have on the quality-of-life of patients and their caregivers?
c. What evidence is there to support the efficacy of available treatments for ARG1-D?
d. What are the limitations of existing interventions (i.e., what is the unmet need)?
